Inorganic Chemistry
Article
(brs, 1H), 6.09 (s, 1H), 1.42 (s, 9H); FT-IR ν cm−1 (KBr) 3329, 2935,
1673, 1528, 1454, 1442.
response in electronic and fluorescence spectra in the visible
region. The selectivity, binding constant values, and detection
limits are praiseworthy and are comparable with the reported
structures of various architectures (Table S2 in the Supporting
Information). However, the response of the compounds
depends on the nature of the α-substitutions of the amino
acid motifs. Experimental results reveal that the rhodamine−
benzimidazole conjugate without α-substitution at the amino
acid motif (compound 3 in the present case) is evaluated to be
stable to metal ions and acid as well. The substitutions at the α-
positions of the benzimidazoles presumably influence the
orientation of the spirolactam rings with the benzimidazoles
and xanthene nucleus and regulate the ring opening differently
toward binding of metal ion. The crystal structure analysis and
theoretical insight explain the reactivity profiles. As compounds
1 and 2 work under physiological conditions, both compounds
are preferred for use either as colorimetric staining agents or as
reagents for imaging studies with biological and environmental
samples. In practice, both 1 and 2, when applied in human lung
carcinoma cell line A549, could detect successfully the cellular
uptake of Al3+ ion.
tert-Butyl (1H-Benzo[d]imidazol-2-yl)methylcarbamate19 (9).
Using the strategy followed for compound 7, compound 9 was
1
prepared in 88% yield: mp 174 °C; H NMR (400 MHz, CDCl3) δ
10.30 (s, 1H), 7.70 (br s, 1H), 7.52 (br s, 1H), 7.25−7.23 (m, 2H),
5.55 (br t, 1H), 4.51 (d, 2H, J = 8 Hz), 1.30 (s, 9H); FT-IR ν cm−1
(KBr) 3348, 2978, 2931, 2751, 1688, 1529.
Compound 1. To synthesize compound 1, a solution of
rhodamine B (0.1 g, 0.2 mmol) in 1,2-dichloroethane (10 mL) was
stirred and phosphorus oxychloride (250 μL) was added dropwise at
room temperature. Then the resulting solution was refluxed for 2 h.
The reaction mixture was cooled and evaporated in vacuo to give
rhodamine B acid chloride 13, which was used in the next step directly.
The acid chloride was dissolved in dry dichloromethane (10 mL) and
was added dropwise over 10 min to a solution of amine 10 (0.06 g,
0.317 mmol; obtained from deprotection of Boc-group in 7 using
TFA) and Et3N (70 μL) in dichloromethane (10 mL) at room
temperature and stirred for 8 h. After completion of the reaction as
monitored by TLC, the solvent was removed under pressure and the
residue was dissolved in chloroform, extracted with water, and dried
over anhydrous Na2SO4. The crude mass was purified by silica gel
column chromatography using petroleum ether/ethyl acetate (7/3 v/
v) as eluent, giving a white powder of compound 1 (0.09 g, yield
70%): mp 96 °C; [α]D25 = −112.13 (c = 0.305 g/100 mL in CHCl3);
1H NMR (400 MHz, CDCl3) δ 10.44 (s, 1H), 7.94 (m, 1H), 7.49 (t,
2H, J = 8 Hz), 7.33 (brm, 2H), 7.14 (t, 1H, J = 4 Hz), 7.07 (brm, 2H),
6.55 (d, 1H, J = 8 Hz), 6.43 (d, 1H, J = 4 Hz), 6.38 (d, 1H, J = 8 Hz),
6.33 (d, 1H, J = 8 Hz), 5.64 (d, 1H, J = 8 Hz), 5.25 (d, 1H, J = 8 Hz),
3.82 (d, 1H, J = 10.8 Hz), 3.39−3.34 (m, 4H), 3.20−3.09 (m, 2H),
3.01−2.94 (m, 2H), 1.72 (brs, 1H), 1.18 (t, 6H, J = 7.20 Hz), 0.95 (t,
6H, J = 7.20 Hz), 0.62 (t, 6H, J = 7.20 Hz); 13C NMR (100 MHz,
CDCl3) δ 168.2, 153.6, 153.2, 152.4, 151.5, 148.1, 147.5, 131.8, 131.1,
129.4, 127.2, 125.9, 123.2, 121.5, 120.5, 106.6, 106.4, 103.3, 103.0,
97.02, 96.6, 66.4, 59.4, 43.4, 43.0, 28.4, 19.8, 19.0, 11.56, 11.53; FT-IR
ν cm−1 (KBr) 3333, 2965, 2928, 1669, 1634, 1616, 1515; HRMS
(TOF MS ES+) calcd for (M + H)+ 614.3495, found 614.3495.
Compound 2. According to the procedure as followed for the
synthesis of 1, compound 2 was prepared (0.092 g, yield 68%); mp
216 °C; [α]D25 = −0.8 (c = 0.6 g/100 mL in CH3OH); 1H NMR (400
MHz, d6-DMSO) δ 11.48 (s, 1H), 7.82 (d, 1H, J = 8 Hz), 7.57−7.55
(m, 2H), 7.43 (d, 1H, J = 8 Hz), 7.34 (d, 1H, J = 8 Hz), 7.11−7.02 (m,
6H), 6.88 (d, 2H, J = 4 Hz), 6.45 (d, 1H, J = 8 Hz), 6.38 (s, 1H),
6.28−6.19 (m, 3H), 5.85 (d, 1H, J = 8 Hz), 5.34 (s, 1H), 3.50−3.30
(m, 4H, buried under signal of solvent), 3.16- 3.11 (m, 4H), 1.09 (t,
6H, J = 8 Hz), 0.91 (t, 6H, J = 8 Hz); 13C NMR (100 MHz, d6-
DMSO) δ 166.9, 153.4, 153.3, 153.0, 152.5, 148.8, 148.6, 142.9, 138.4,
134.8, 133.5, 131.7, 129.8, 129.5, 128.8, 128.6, 128.0, 127.3, 124.3,
122.9, 122.1, 121.2, 118.7, 112.1, 108.5, 107.9, 104.8, 104.1, 97.4, 66.4,
56.2, 44.2, 44.0, 12.8, 12.7; FT-IR ν cm−1 (KBr) 3293, 2966, 1685,
1635, 1615, 1545, 1514; HRMS (TOF MS ES+): C calcd for (M + H)+
648.3339, found 648.3364.
EXPERIMENTAL SECTION
■
(S)-tert-Butyl 1-(2-Aminophenylamino)-3-methyl-1-oxobu-
tan-2-ylcarbamate18 (4). To a stirred solution of N-Boc-protected
L-valine acid (1 g, 4.6 mmol) in dry CH2Cl2 (15 mL) was added DCC
(1 g, 4.84 mmol) at 0 °C. The solution was stirred for 30 min, and a
solution of o-phenylenediamine (2.5 g, 23.11 mmol) in dry CH2Cl2
(35 mL) was added to it under a nitrogen atmosphere. After it was
stirred for 19 h, the reaction mixture was filtered off to remove
insoluble DCU. The filtrate was removed in vacuo, and the crude
product was purified by silica gel column chromatography using 1%
CH31OH in CHCl3 to afford compound 4 (0.92 g, yield 65%): mp 132
°C; H NMR (400 MHz, CDCl3) δ 7.75 (s, 1H), 7.21 (d, 1H, J = 8
Hz), 7.05 (t, 1H, J = 8 Hz), 6.79−6.75 (m, 2H), 5.12 (br s, 1H), 3.99
(t, 1H, J = 8 Hz), 3.87 (s, 2H), 2.29−2.25 (m, 1H), 1.65 (s, 9H),
1.12−1.01 (m, 6H); FT-IR ν cm−1 (KBr) 3420, 3339, 3257, 3044,
2980, 1703, 1678, 1538.
(S)-tert-Butyl 2-(2-Aminophenylamino)-2-oxo-1-phenyle-
thylcarbamate (5). Using the same strategy as for compound 4,
we synthesized compound 5 (yield 68%); mp 138 °C; 1H NMR (400
MHz, CDCl3) δ 7.78 (s, 1H), 7.44 (d, 2H, J = 8 Hz), 7.38−7.32 (m,
3H), 7.11 (d, 1H, J = 8 Hz), 7.01 (t, 1H, J = 8 Hz), 6.74−6.69 (m,
2H), 5.87 (d, 1H, J = 4 Hz), 5.36 (s, 1H), 3.65 (s, 2H), 1.42 (s, 9H);
FT-IR ν cm−1 (KBr) 3347, 3257, 2977, 1708, 1661, 1523, 1456.
(S)-tert-butyl 1-(1H-benzo[d]imidazol-2-yl)-2-methylpropyl-
carbamate18 (7). Compound 4 (0.5 g, 1.63 mmol) was next heated
in acetic acid (0.5 mL) at 80 °C for 2 h. Then the reaction mixture was
quenched by addition of an aqueous solution of NaHCO3 (15 mL).
The reaction mixture was next extracted with a CHCl3/MeOH solvent
mixture (CHCl3/MeOH 3/1 v/v; 20 mL). The organic layer was
washed with brine, dried over Na2SO4, and evaporated under reduced
pressure. The reaction mixture was purified by silica gel column
chromatography using 40% petroleum ether in ethyl acetate to afford
Compound 3. According to the procedure followed for the
synthesis of 1, compound 3 was prepared (0.12 g, yield 67%): mp 160
°C; 1H NMR (400 MHz, CDCl3) δ 9.90 (s, 1H), 7.96−7.94 (m, 1H),
7.48−7.44 (m, 3H), 7.26 (s, 1H), 7.14−7.07 (m, 3H), 6.37 (d, 2H, J =
2.4 Hz), 6.22 (s, 1H), 6.20 (s, 1H), 5.94 (dd, 2H, J1 = 8 Hz, J2 = 4 Hz),
4.56 (s, 2H), 3.27−3.17 (m, 8H), 1.08 (t, 12H, J = 8 Hz); 13C NMR
(100 MHz, CDCl3) δ 169.2, 153.6, 153.4, 150.8, 148.8, 133.0, 130.3,
128.2, 128.0, 124.0, 122.8, 121.9, 108.4, 107.8, 103.9, 97.8, 65.8, 44.2,
38.2, 12.5; FT-IR ν cm−1 (KBr) 3512, 2970, 1693, 1680, 1634, 1615,
1547, 1515; HRMS (TOF MS ES+) calcd for (M + H)+ 572.3026,
found 572.3018.
Quantum Yield Determination. Quantum yields (Φ) of the
compounds 1−3 by themselves and in the presence of Al3+ were
determined in CH3CN by a relative comparison procedure using
rhodamine B as standard (Φrh 6G = 0.95 in ethanol).20a The general
equation used for determination of relative quantum yields is20b
1
the compound 7 (0.415 g, yield 88%): mp 174 °C; H NMR (400
MHz, CDCl3 containing one drop of d6-DMSO) δ 10.70 (s, 1H), 7.71
(d, 1H, J = 8 Hz), 7.35 (d, 1H, J = 8 Hz), 7.21−7.19 (m, 2H), 5.67 (d,
1H, J = 8 Hz), 4.61 (t, 1H, J = 8 Hz), 2.47−2.45 (m, 1H), 1.43 (s,
9H), 1.06 (d, 3H, J = 4 Hz), 0.93 (d, 3H, J = 4 Hz); 13C NMR (100
MHz, CDCl3 containing one drop of d6-DMSO) δ 155.6, 154.9, 121.7
(four carbons unresolved), 79.2, 55.1, 33.2, 28.2, 19.2, 18.3; FT-IR ν
cm−1 (KBr) 3333, 2974, 2930, 1675, 1628, 1536.
(S)-tert-Butyl (1H-Benzo[d]imidazol-2-yl)(phenyl)-
methylcarbamate (8). Using the strategy followed for compound
7, compound 8 was prepared in 85% yield: mp 190 °C; 1H NMR (400
MHz, CDCl3) δ 10.15 (s, 1H), 7.71 (d, 1H, J = 8 Hz), 7.36 (m, 2H),
7.35−7.29 (m, 2H), 7.27−7.25 (m, 2H), 7.24−7.19 (m, 2H), 6.24
Φ = (ΦF Asλexsη2 )/(FAuλexuη2 )
u
s
u
s
u
s
H
Inorg. Chem. XXXX, XXX, XXX−XXX